Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Management of liver complications in sickle cell disease

Abid R. Suddle

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 345–350.

https://doi.org/10.1182/hematology.2019000037

Published: 2019

Journal Articles

Primary immunodeficiencies: novel genes and unusual presentations

Luigi D. Notarangelo, Gulbu Uzel, V. Koneti Rao

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 443–448.

https://doi.org/10.1182/hematology.2019000051

Published: 2019

Journal Articles

Monitoring and treatment of MDS in genetically susceptible persons

Stella M. Davies

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 105–109.

https://doi.org/10.1182/hematology.2019000020

Published: 2019

Journal Articles

JAK2 (and other genes) be nimble with MPN diagnosis, prognosis, and therapy

Michele Ciboddo, Ann Mullally

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 110–117.

https://doi.org/10.1182/asheducation-2018.1.110

Published: 2018

Journal Articles

The MDS genomics-prognosis symbiosis

Aziz Nazha

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 270–276.

https://doi.org/10.1182/asheducation-2018.1.270

Published: 2018

Journal Articles

A brief, but comprehensive, guide to clonal evolution in aplastic anemia

Daria V. Babushok

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 457–466.

https://doi.org/10.1182/asheducation-2018.1.457

Published: 2018

Journal Articles

Role of the microenvironment across histological subtypes of NHL

Karin Tarte

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 610–617.

https://doi.org/10.1182/asheducation-2017.1.610

Published: 2017

Journal Articles

Myeloproliferative neoplasms: from origins to outcomes

Jyoti Nangalia, Anthony R. Green

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 470–479.

https://doi.org/10.1182/asheducation-2017.1.470

Published: 2017

Journal Articles

Diagnosing von Willebrand disease: genetic analysis

Anne Goodeve

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 678–682.

https://doi.org/10.1182/asheducation-2016.1.678

Published: 2016

Journal Articles

New insights into genotype and phenotype of VWD

Veronica H. Flood

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 531–535.

https://doi.org/10.1182/asheducation.V2014.1.531.3883265

Published: 2014

Journal Articles

Impact of MYC on malignant behavior

German Ott

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 100–106.

https://doi.org/10.1182/asheducation-2014.1.100

Published: 2014

Journal Articles

The evolving genomic landscape of myeloproliferative neoplasms

Jyoti Nangalia, Tony R. Green

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 287–296.

https://doi.org/10.1182/asheducation-2014.1.287

Published: 2014

Journal Articles

Clinical and laboratory diagnosis of VWD

Augusto B. Federici

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 524–530.

https://doi.org/10.1182/asheducation-2014.1.524

Published: 2014

Journal Articles

How does JAK2V617F contribute to the pathogenesis of myeloproliferative neoplasms?

Edwin Chen, Ann Mullally

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 268–276.

https://doi.org/10.1182/asheducation-2014.1.268

Published: 2014

Journal Articles

von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy

David Lillicrap

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 254–260.

https://doi.org/10.1182/asheducation-2013.1.254

Published: 2013

Journal Articles

Hemochromatosis: the new blood donor

Susan F. Leitman

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 645–650.

https://doi.org/10.1182/asheducation-2013.1.645

Published: 2013

Journal Articles

Focus on the epigenome in the myeloproliferative neoplasms

Eunhee Kim, Omar Abdel-Wahab

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 538–544.

https://doi.org/10.1182/asheducation-2013.1.538

Published: 2013

Journal Articles

Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?

Stefan N. Constantinescu, William Vainchenker

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 553–560.

https://doi.org/10.1182/asheducation.V2012.1.553.3800163

Published: 2012

Journal Articles

The many faces of common variable immunodeficiency

Charlotte Cunningham-Rundles

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 301–305.

https://doi.org/10.1182/asheducation.V2012.1.301.3798316

Published: 2012

Journal Articles

Diamond Blackfan Anemia

Sarah Ball

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 487–491.

https://doi.org/10.1182/asheducation-2011.1.487

Published: 2011

NARROW

Management of liver complications in sickle cell disease

Primary immunodeficiencies: novel genes and unusual presentations

Monitoring and treatment of MDS in genetically susceptible persons

JAK2 (and other genes) be nimble with MPN diagnosis, prognosis, and therapy

The MDS genomics-prognosis symbiosis

A brief, but comprehensive, guide to clonal evolution in aplastic anemia

Role of the microenvironment across histological subtypes of NHL

Myeloproliferative neoplasms: from origins to outcomes

Diagnosing von Willebrand disease: genetic analysis

New insights into genotype and phenotype of VWD

Impact of MYC on malignant behavior

The evolving genomic landscape of myeloproliferative neoplasms

Clinical and laboratory diagnosis of VWD

How does JAK2V617F contribute to the pathogenesis of myeloproliferative neoplasms?

von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy

Hemochromatosis: the new blood donor

Focus on the epigenome in the myeloproliferative neoplasms

Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?

The many faces of common variable immunodeficiency

Diamond Blackfan Anemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only